abstract |
The present invention relates to new compounds of formula (I), wherein Q is a partially saturated ring or Nl-oxides, salts, solvates or solvated salts thereof, processes for their preparation and new intermediates used in the preparation thereof and to the use of said compounds as metabotropic glutamate receptors ligands in therapy. |